Michael Hallek to Hepatitis B Core Antigens
This is a "connection" page, showing publications Michael Hallek has written about Hepatitis B Core Antigens.
Connection Strength
0.047
-
HBsAg-negative/anti-HBc-positive patients treated with rituximab: prophylaxis or monitoring to prevent hepatitis B reactivation? Infection. 2019 Apr; 47(2):293-300.
Score: 0.047
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.